NCT02392130View on ClinicalTrials.gov

A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Skin Tissue DiseasesConnective Tissue Diseases
Interventions
DRUG

Clobetasol propionate 0.05% ointment

DRUG

LEO 130852A gel 1%

DRUG

LEO 130852A placebo gel

Trial Locations (1)

20095

bioskin GmbH, Hamburg

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY